Lv5
1366 积分 2023-09-18 加入
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
27天前
已完结
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial
27天前
已完结
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial
27天前
已完结
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
27天前
已完结
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial
27天前
已完结
EAES rapid guideline: complete mesocolic excision for right-sided colon cancer-with SAGES and ESCP participation
27天前
已完结
EAES, ESCP, and ESGAR clinical practice guideline update on taTME for rectal cancer
27天前
已完结
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
27天前
已完结
Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trial
27天前
已完结
Long-Term Survival on Extent of Lymphadenectomy for Right-Sided Colon Cancer: Five-Year Follow-up Results of a Randomized Controlled Trial (RELARC Trial)
27天前
已关闭
皖公网安备34019202002308
